Aron Knickerbocker’s Post

As scientists we have our own biases towards what's trending in #drugdiscovery. I am not sure the #privateequity #VC community always agrees. I am delighted that Jernej Godec, Jenna Hebert, James Kasuboski, Jasmina Marjanovic and Swetha Murali are joining us at #BostonDOT24 to share their thoughts on -Key drivers of innovation in drug discovery -Improvements in translating discoveries from the lab to the clinic -Impact of emerging areas like AI/machine learning, targeted degraders and molecular glues -Perspectives on current challenges and opportunities Why wait until then to get talking?! https://lnkd.in/e3ED9js2

Anything #drugdiscovery you would like to see discussed at the upcoming #BostonDOT24 event? Final agenda now online but we are putting together topics for informal breakout discussions that seem to be very conducive for brainstorming and collaborations. Here are some that are already on my list #molecularglues #transcriptionfactors #proteindegraders #AI #ML #RNAtargets #3Dmodels https://lnkd.in/eQ5RvdTW

Our latest episode of the Alldus, “AI in Action” Podcast features Drew Linsley from Operant Biopharma. Here Drew talks us through his journey and how Operant are using AI to autonomously design biological experiments, discovering and optimizing disease treatments. It’s another example of the groundbreaking work across the AI world. If you are a business leader doing innovative work in AI and would be interested in featuring on the podcast, we’d love to hear from you. #biopharma #artificialintelligence #aiinaction

Tune in to Episode 2 of ACRO's Good Clinical Podcast, where Stephen Pyke and the FDA's Dr. Tala Fakhouri discuss the massive potential of AI in clinical research. 🎙   Learn more about the FDA's evidentiary standards for AI, the importance of methodological transparency in submissions and how AI stands to streamline the drug development process, helping to bring life-changing medicines to market more efficiently. 💡 Stephen also sheds light on where AI advancements will show up and what it means for patients. 👇 Watch below! Don’t miss this fascinating discussion. Access the full episode here: https://lnkd.in/gdMz_agR #ACRO #GoodClinicalPodcast #ArtificialIntelligence 

“Driving Drug Discovery Efficiencies in Life Sciences with AI - with Anne Phelan of BenevolentAI” https://lnkd.in/eKVZwjGz On Emerj Artificial Intelligence Research’s ‘AI in Healthcare and Life Sciences’ podcast, BenevolentAI CSO Anne Phelan discusses the high costs of failed drug targets and how AI-enhanced techniques can mitigate these expenses. She explains how AI is revolutionizing how not only drugs are targeted, but also the patients that receive them: “I think the AI has given us a much more granular picture of stratification. There is a diagnostic component to the stratification. It's the extent of the symptoms that the patients suffer from, the extent of the inflammation in the colon. There is a kind of clinical diagnostic component to this, but actually, the AI is allowing us to layer on top of that much more molecular patient signatures. So that we can start to understand, in much more detail, why patients might be classed might be experiencing very severe symptoms. We can start to understand that at a much more molecular level.”

Companies are pushing to embed AI into every aspect of the drug discovery process where biotech and big tech merge to attack human disease with artificial intelligence, but how beneficial is it? Read on to find out. #ai #biotech #drugdiscovery #drugresearch https://lnkd.in/dT6upRpt

Following extensive research within our community, the Lab of the Future Congress Europe 2024 includes case studies and use cases from exciting biopharma experts, insightful sessions on collaborative research partnerships, and discussions on how to address the challenges of onboarding novel technologies in research, development, and manufacturing. The multi-track program is focused on the following themes: -       AI to Innovate -       AI to Optimize -       Supporting the Biotechs of the Future -       Connected Lab -       Automated Lab -       Digital Transformation -       Data Strategy -       Lab Operational Excellence Learn more here:  https://lnkd.in/exU8kGHB #labofthefuture #ai #digitaltransformation #lotfeu2024

Learn how to prepare for the future of AI-driven scientific research at this upcoming webinar hosted by Shape Therapeutics Inc. & Benchling! Join us on Wednesday, April 24th at 12pm PST and register now to secure your spot. This webinar will cover how to reset your R&D with AI-ready data and AI-enabled scientists for scalable scientific results. Register today using the link below! #AI #scientificresearch #webinar #celltherapy #antibodyresearch #genetherapy #infectiousdisease #RNA #mRNA

This episode provides valuable insights into the augmented role that AI is playing in healthcare and drug discovery, showcasing some innovative solutions and advancements. From expediting the IND for the FDA process to significantly reducing time and costs, these developments highlight the transformative power of data in driving efficiency and progress.

Interested in the intersection of art and #artificialintelligence? See what happens when you ask leading #AI executives to prompt their AI counterparts to create works of art ---> #NYSE's (ART)ificial Intelligence is live, see below!